Stoneridge Grew 26% and Still Got a $25 Million Bill From a Product It Exited in 2019
The best revenue growth in three years and the best EBITDA in nine quarters — met by a guidance cut to the bottom of the range and a warranty ruling that outsizes the market cap by a fifth
SRI · Earnings Call · 2026-11-05
The best top line in three years, priced like a warning
For six quarters Stoneridge has sold the same simple promise: the commercial-vehicle trough will end, and when it does an under-utilized cost base will convert volume into margin. The third quarter finally delivered the first half. Weighted-average OEM production rose nearly 18% year over year and Stoneridge outgrew it by roughly 8 points on the way to adjusted revenue of $180 million, up 30% reported. “This was the fastest rate of organic growth in over three years and a meaningful acceleration versus the 8% rate of growth generated in the second quarter.” — Natalia Noblet, Chief Executive Officer · 2026-11-05 The rate of growth is not a rounding artifact: it came from North American commercial vehicle, a record $37 million of MirrorEye sales (+48%), and double-digit growth at Stoneridge Brazil. There is a second, quieter data point that matters more than the headline. A new existing vision system order — explicitly not MirrorEye — is expected to generate roughly $180 million of cumulative sales through 2028, ramping from the start of 2027. Management would not say what it is: “this is not MirrorEye. This is another vision system, another camera system” — Natalia Noblet, Chief Executive Officer · 2026-11-05. A confidential, ~$180 million award that is not the flagship product is the kind of thing a $136 million market cap does not get credit for until the revenue shows up. Operationally the leverage is arriving. SG&A fell 317 basis points to 13.1% of sales, absorbing a $41 million year-over-year revenue increase with only $1 million of extra spend, and adjusted EBITDA of $7.3 million was the strongest in nine quarters off a 4.1% margin. The stock, however, is not participating: down 11.9% over the ninety trading days into this print, 20% off its late-June high, and 84% below its 2021 peak. At 0.3x price to revenue, the equity is a call option on the second half of the promise.Two invoices from a business they already sold
On October 30 an arbitrator ruled against Stoneridge on warranty claims brought by a customer of its former Control Devices business, awarding roughly $25.5 million on a PM sensor line the company exited in 2019 — a case managed in an Italian court. Stoneridge took a ~$24 million non-cash pre-tax charge, net of existing accruals, as a reduction to net sales, and is unambiguous about its view: “We disagree with the ruling and continue to believe the claims lack merit.” — Natalia Noblet, Chief Executive Officer · 2026-11-05 The cash is there ($63 million) but the optics are poor, because in March the CFO had drawn a clean line around exactly this: “When we referred to legacy warranty questions, those were legacy warranty questions for issues within our Electronics products themselves. Any warranty that related to Control Devices was passed with the business to the new buyer.” — Matthew R. Horvath, Chief Financial Officer · 2026-03-12 Both statements can be legally true — management says the claim has been disclosed since 2023 — but the market only hears that the divested segment can still send invoices. Layered on top: $3 million of negotiated settlements on other legacy matters, taken inside adjusted EBITDA rather than backed out, plus strategic inventory-related expenses. This is a quality-cost story that has been running for years. In February 2025 the same CFO explained the mechanics: “when we find a quality issue, the accrual requires us to take into account all the future expectations for those issues. So that's why you get a little bit of lumpiness.” — Matt Horvath, Chief Financial Officer · 2025-02-27 A $25.5 million arbitration ruling on a 2019-exited part is lumpiness with a very long tail.The input that eats the recovery
Gross margin fell 382 basis points to 19.9%, swallowing the SG&A improvement and leaving operating margin at just 0.4%. The culprit is not demand. It is components — specifically memory. “The biggest, I would say, overhang that we have been trying to work through in Q3 as well has been inflationary pressures, especially around memory.” — Scott Humphrey, Chief Financial Officer · 2026-11-05 This is a genuinely shared wave rather than a Stoneridge failing: elevated memory costs surfaced at AOSL this week, and the market's own theme set has carried memory cost, memory pricing and memory supply as top-ranked concerns through recent quarters. The semiconductor supply chain, for its part, has been sold hard — high bandwidth memory names were among the worst 30-day decliners — which suggests the market believes relief is coming even as procurement teams do not. That tension produced the guidance structure. Revenue was raised to $690–700 million, a $37.5 million lift at the midpoint; adjusted EBITDA was pushed to the bottom of the $20–25 million range. Gross margin of 20.3% in the latest filed quarter, 5 points lower over five years. Even at the midpoint, the implied fourth quarter is over 20% revenue growth and roughly 60% EBITDA growth — and management is telling you it may not collect it.with the fourth quarter being a seasonally small production period for many of our OEM customers, and given the inventory investments we are making to support several major OEM programs that will ramp during the first half of 2027, there is increased uncertainty whether we can fully realize additional inflationary recovery measures during the year.